IP Library › Assignment 072160/0981
Patent Assignment
Reel/Frame 072160/0981

Assignment of Assignor's Interest

Recorded: 2025-09-04 Pages: 5
Assignor
SUMITOMO PHARMA CO., LTD.
Executed: 2025-07-10
Assignee
INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
13-9, ENOKI-CHO, SUITA-SHI, OSAKA, 564-0053, JAPAN
Covered Properties (11)
Peptides Comprising an Epitope of the Wilms Tumor Gene Product
Patent: 7,939,627 →
Application: 12/095,418 →
Publication: US 2010/0062010
Method for Cancer Immunotherapy
Patent: 8,575,308 →
Application: 13/053,996 →
Publication: US 2011/0229506
Method for Cancer Immunotherapy
Patent: 9,273,148 →
Application: 14/022,413 →
Publication: US 2014/0046036
WT1 Antigen Peptide Conjugate Vaccine
Patent: 9,181,302 →
Application: 14/549,091 →
Publication: US 2015/0080321
WT1 Antigen Peptide Conjugate Vaccine
Patent: 9,248,173 →
Application: 14/706,772 →
Publication: US 2015/0238587
Method for Cancer Immunotherapy
Patent: 9,765,114 →
Application: 15/054,805 →
Publication: US 2016/0168197
WT1 Antigen Peptide Conjugate Vaccine
Application: 16/163,067 →
Publication: US 2019/0030149
WT1 Helper Peptides and Combinations of WT1 Helper Peptide and Conjugate of Cancer Antigen Peptides
Application: 16/464,950 →
Publication: US 2020/0016255
Composition for Preventing or Treating Benign Tumor
Application: 17/282,172 →
Publication: US 2022/0008528
Pharmaceutical Composition for Treating Cancer
Application: 17/998,430 →
Publication: US 2023/0183316
Combination Use of WT1 Antigen Peptide and Immunomodulator
Application: 18/538,960 →
Publication: US 2024/0293521
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 30, 2008
From: NISHIHARA, TOSHIO; GOTOH, MASASHI
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.; CHUGAI SEIYAKU KABUSHIKI KAISHA; DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 021020/0343 →
Change of Name Oct 10, 2014
From: DAINIPPON SUMITOMO PHARMA CO., LTD.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 033969/0194 →
Assignment of Partial Rights May 4, 2015
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 035571/0862 →
Assignment of Assignor's Interest May 4, 2015
From: LI, CHIANG JIA; BAN, HITOSHI; NISHIO, YUKIHIRO; GOTO, MASASHI
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 035552/0990 →
Assignment of Assignor's Interest Apr 25, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 038364/0495 →
Assignment of Assignor's Interest Jul 18, 2016
From: CHUGAI SEIYAKU KABUSHIKI KAISHA
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 039176/0080 →
Assignment of Assignor's Interest May 29, 2019
From: BAN, HITOSHI; GOTO, MASASHI; TAKANASHI, YOSUKE
To: SUMITOMO DAINIPPON PHARMA CO., LTD.; INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 049308/0264 →
Assignment of Assignor's Interest Apr 1, 2021
From: SUGIYAMA, HARUO
To: INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.; SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 055807/0161 →
Change of Name Jun 10, 2022
From: SUMITOMO DAINIPPON PHARMA CO., LTD.
To: SUMITOMO PHARMA CO., LTD.
Reel/Frame 060161/0046 →
Assignment of Assignor's Interest Nov 10, 2022
From: GOTO, MASASHI; SUGINOBE, NATSUKO; NAKAMURA, MEGUMI
To: SUMITOMO PHARMA CO., LTD.; INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC.
Reel/Frame 061722/0508 →